People: Alkermes Plc (ALKS.O)

ALKS.O on Nasdaq

44.66USD
22 Oct 2014
Price Change (% chg)

$0.86 (+1.96%)
Prev Close
$43.80
Open
$44.28
Day's High
$44.79
Day's Low
$43.38
Volume
725,526
Avg. Vol
864,877
52-wk High
$54.25
52-wk Low
$34.28

Search Stocks

Stejbach, Mark 

Brief Biography

Mr. Mark Stejbach is Senior Vice President, Chief Commercial Officer of Alkermes PLC. Prior to assuming this position, Mr. Stejbach served at Tengion, Inc. from 2008 to 2012, as its Chief Commercial Officer. He previously held senior positions at Merck & Co. and Biogen Idec Inc. and has 25 years of experience in biotech and pharmaceutical marketing, sales, managed care, and finance. Mr. Stejbach served on the charitable board of the Commonwealth National Fund from 2003 through 2011 and has served on the Advisory Board of the Center for Value-Based Insurance Design since 2009.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Richard Pops

6,587,780

Shane Cooke

3,164,580

James Frates

1,831,190

Gordon Pugh

1,965,720

Kathryn Biberstein

2,113,310

Rebecca Peterson

--
As Of 30 Mar 2013
Search Stocks